Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2018

Open Access 01-09-2018 | Gastrointestinal Oncology

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden

Authors: Johannes Asplund, MD, Joonas H. Kauppila, PhD, Fredrik Mattsson, BSc, Jesper Lagergren, PhD

Published in: Annals of Surgical Oncology | Issue 9/2018

Login to get access

Abstract

Background

Gastric adenocarcinoma is the second most common cancer-related death globally. Assessing survival trends can help evaluate changes in detection and treatment. We aimed to determine recent prognosis trends in gastric non-cardia and cardia adenocarcinoma in an unselected cohort with complete follow-up.

Methods

Population-based nationwide cohort study, including 17,491 patients with gastric non-cardia adenocarcinoma and 4698 with cardia adenocarcinoma recorded in the Swedish Cancer Registry in 1990–2013 with follow-up until 2017. Observed and relative 5-year survival was calculated and stratified by resectional surgery and no such surgery. Prognostic factors were evaluated using multivariable Cox regression.

Results

The relative overall 5-year survival remained stable at 18% for gastric non-cardia adenocarcinoma throughout the study period and increased from 12 to 18% for cardia adenocarcinoma. Concurrently, the proportion of patients who underwent resectional surgery decreased from 49 to 38% for non-cardia adenocarcinoma and from 48 to 33% for cardia adenocarcinoma. The relative postoperative 5-year survival increased from 33 to 44% for non-cardia adenocarcinoma and from 21 to 43% for cardia adenocarcinoma, whereas in nonoperated patients it decreased from 3 to 2% in non-cardia adenocarcinoma and increased from 3 to 5% in cardia adenocarcinoma. Poor prognostic factors were higher tumor stage, older age, and more comorbidity.

Conclusions

Despite decreasing resectional rates, the 5-year overall survival has remained unchanged for gastric non-cardia adenocarcinoma and improved for cardia adenocarcinoma over the last two decades in Sweden and is now similar for these sublocations. The postoperative survival has improved for both sublocations, but particularly for cardia adenocarcinoma.
Literature
1.
go back to reference Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19(8):36.CrossRefPubMed Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19(8):36.CrossRefPubMed
2.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
3.
go back to reference Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer. Lancet (London, England) 388(10060):2654–64.CrossRef Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer. Lancet (London, England) 388(10060):2654–64.CrossRef
4.
go back to reference Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control CCC. 2008;19(7):689–701.CrossRefPubMed Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control CCC. 2008;19(7):689–701.CrossRefPubMed
5.
go back to reference Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4(4):175–85.PubMedPubMedCentral Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4(4):175–85.PubMedPubMedCentral
6.
go back to reference Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64(12):1881–88.CrossRefPubMed Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64(12):1881–88.CrossRefPubMed
7.
go back to reference HACC group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49(3):347–53CrossRef HACC group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49(3):347–53CrossRef
8.
go back to reference Amini N, Spolverato G, Kim Y, et al. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study. J Surg Oncol. 2015;111(3):285–92.CrossRefPubMed Amini N, Spolverato G, Kim Y, et al. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study. J Surg Oncol. 2015;111(3):285–92.CrossRefPubMed
9.
go back to reference Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. Eur J Cancer (Oxford, England: 1990) 2015;51(9):1164–87.CrossRef Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. Eur J Cancer (Oxford, England: 1990) 2015;51(9):1164–87.CrossRef
11.
12.
go back to reference de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin N Am. 2013;42(2):219–40.CrossRefPubMed de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin N Am. 2013;42(2):219–40.CrossRefPubMed
13.
go back to reference Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5. Eur J Cancer (Oxford, England: 1990) 2015;51(15):2144–57.CrossRef Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5. Eur J Cancer (Oxford, England: 1990) 2015;51(15):2144–57.CrossRef
14.
go back to reference Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (Oxford, England: 1990) 2010;46(6):1101–10.CrossRef Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (Oxford, England: 1990) 2010;46(6):1101–10.CrossRef
15.
16.
go back to reference Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91(9):786–90.CrossRefPubMed Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91(9):786–90.CrossRefPubMed
17.
go back to reference Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99.
18.
19.
go back to reference Lagergren K, Derogar M. Validation of oesophageal cancer surgery data in the Swedish Patient Registry. Acta Oncol. 2012;51(1):65–68.CrossRef Lagergren K, Derogar M. Validation of oesophageal cancer surgery data in the Swedish Patient Registry. Acta Oncol. 2012;51(1):65–68.CrossRef
20.
go back to reference Armitage JN, van der Meulen JH. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Br J Surg. 2010;97(5):772–81.CrossRefPubMed Armitage JN, van der Meulen JH. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. Br J Surg. 2010;97(5):772–81.CrossRefPubMed
21.
go back to reference Swedish Causes of Death Registry: Bortfall och kvalitet i dödsorsaksregistret. 2010. Swedish Causes of Death Registry: Bortfall och kvalitet i dödsorsaksregistret. 2010.
22.
go back to reference Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958;8(6):699–712.CrossRefPubMed Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958;8(6):699–712.CrossRefPubMed
23.
go back to reference Brusselaers N, Vall A, Mattsson F, Lagergren J. Tumour staging of oesophageal cancer in the Swedish Cancer Registry: a nationwide validation study. Acta Oncol (Stockholm, Sweden). 2015;54(6):903–8.CrossRef Brusselaers N, Vall A, Mattsson F, Lagergren J. Tumour staging of oesophageal cancer in the Swedish Cancer Registry: a nationwide validation study. Acta Oncol (Stockholm, Sweden). 2015;54(6):903–8.CrossRef
24.
go back to reference Little RJA, Rubin DB. Statistical analysis with missing data. Chicester: Wiley; 2016. Little RJA, Rubin DB. Statistical analysis with missing data. Chicester: Wiley; 2016.
25.
go back to reference Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Stomach cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123 Suppl 24:4994–5013.CrossRefPubMedPubMedCentral Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Stomach cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123 Suppl 24:4994–5013.CrossRefPubMedPubMedCentral
26.
go back to reference Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49(2):292–305.CrossRefPubMedPubMedCentral Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49(2):292–305.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Zhao J, Zhao J, Du F, et al. Cardia and non-cardia gastric cancer have similar stage-for-stage prognoses after R0 resection: a large-scale, multicenter study in China. J Gastrointest Surg. 2016;20(4):700–7.CrossRefPubMed Zhao J, Zhao J, Du F, et al. Cardia and non-cardia gastric cancer have similar stage-for-stage prognoses after R0 resection: a large-scale, multicenter study in China. J Gastrointest Surg. 2016;20(4):700–7.CrossRefPubMed
29.
go back to reference Young JA, Shimi SM, Kerr L, McPhillips G, Thompson AM. Reduction in gastric cancer surgical mortality over 10 years: an adverse events analysis. Ann Med Surg (2012). 2014;3(2):26–30.CrossRef Young JA, Shimi SM, Kerr L, McPhillips G, Thompson AM. Reduction in gastric cancer surgical mortality over 10 years: an adverse events analysis. Ann Med Surg (2012). 2014;3(2):26–30.CrossRef
30.
go back to reference Nelen SD, Heuthorst L, Verhoeven RHA, et al. Impact of centralizing gastric cancer surgery on treatment, morbidity, and mortality. J Gastrointest Surg. 2017. Nelen SD, Heuthorst L, Verhoeven RHA, et al. Impact of centralizing gastric cancer surgery on treatment, morbidity, and mortality. J Gastrointest Surg. 2017.
Metadata
Title
Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
Authors
Johannes Asplund, MD
Joonas H. Kauppila, PhD
Fredrik Mattsson, BSc
Jesper Lagergren, PhD
Publication date
01-09-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6627-y

Other articles of this Issue 9/2018

Annals of Surgical Oncology 9/2018 Go to the issue